Our study using data from the UK CPRD Aurum published in @CIDJournal shows that metformin use within 90 days of COVID-19 diagnosis reduces post-COVID risk in individuals with overweight/obesity. 📮Read more: https://t.co/eXxp6ohpv7 @ChengshengJ @LiWeiUCL @KennethKCMan

Excited to share our new publication on using DCE and C-TTO to value population mental well-being in Hong Kong. We identified key task features, cultural interpretations, and decision strategies. Thanks to HKU team, and Oxford and Warwick collaborators! https://t.co/y6I2e0c9Q4

New in @bmj_latest: Gabapentinoid treatment not directly linked to increased self-harm risk. Risk is highest before and after treatment—not during. Close monitoring needed across the full treatment journey. Read more:

PhD Opportunity @UCL 🌍 Join our global collaboration with SKKU & partners, tackling key health challenges in mental health & maternal-child health using real-world data! 💡 Open to passionate candidates in epidemiology, stats, pharmacy & more! @FindAPhD:

1/ That "immortal time" is so frequent in survival analyses for #causalinference is fascinating. Because "immortal time" doesn't exist in the data, *we* create it when misanalyzing data. Our paper https://t.co/2TYg6hHCZj summarizes why immortal time arises & how to prevent it.

The @CAUSALab Methods Series at @karolinskainst is back! @jonathanasterne @BristolUni kicks off Fall 2024 with a virtual talk on COVID-19 vaccine effectiveness & OpenSAFELY. Register to attend 👇 https://t.co/p4tKqGZSnc #causalinference #targettrial #publichealth #causal

https://t.co/AxJfotl4oz Our new study shows a reduced use of pharmacological treatment for heart failure after a cancer diagnosis. Better cardio-oncology services are needed for patients living with both conditions. @LiWeiUCL @wallis_lau @PinkieChambers @dr_manisty

Our latest work summarises evidence on sex-based outcomes of anticoagulants in AF. We had to dive into full texts & appendices of >500 papers to find sex-based results. Couldn’t have done this without the team @J_Chobanov @PajareeMaii Edil @ZixuanWang_ZW! https://t.co/9X43EST2Kp

Professor @_MiguelHernan of @HarvardChanSPH discusses "Target Trial Emulation: A Framework for Causal Inference From Observational Data" with JAMA Statistical Editor Roger J. Lewis.

Using a trial emulation framework, we found statins do not lower the risk of cancer in patients with heart failure. @LiWeiUCL @wallis_lau @IntPharmacoEpi https://t.co/0bAr4nOXBb

We are hiring! Are you passionate about improving healthcare with Real-World Data? UCL is looking for a research fellow with strong analytical skills to join our innovative team. Bring your expertise to where it can make a real difference! Apply now:

Would initiating #paxlovid immediately after onset improve clinical outcomes and/or lead to rebound? Please check out our latest @NatureComms paper on the optimal timing of #paxlovid initiation (0-1d vs >1 d after onset or diagnosis). Full-text: https://t.co/EfT0r2XKEA

📣 New from my team in @TheLancetInfDis Long-term outcomes of people hospitalized for COVID-19 vs seasonal influenza A 🧵 https://t.co/GqKod7ktxf

Pregnant women were excluded from PANORAMIC and EPIC-HR trials due to safety concerns. Pax use in pregnant women was rarely studied. Our study found pax was effective in symptomatic pregnant women with omicron infection. Published at @NatureMedicine https://t.co/cjy6QaJHhn

🚨📢 New #LongCovid research from @ReactStudy @imperialcollege 🧵 ♦️ 242,712 adults surveyed ♦️ 10% persistent symptoms 4 weeks+ ♦️ 7.5% symptoms 12 weeks+ ♦️ 5% have symptoms 1 year+ ‼️ ♦️ Fatigue, cognitive dysfunction, joint pain most common 1/3 https://t.co/jMqcYAQsOv

I recently did a brief Q&A with @GoHealio on our latest work. Here is the study: https://t.co/v20GUhKvDj And interview: https://t.co/npbwnGLuRj

1/🧵 COVID & Autoimmune Diseases - more data 💥 My patient w #LongCOVID has new Raynaud’s and SLE (Lupus). She’s in tons of pain and is losing her fingers. Study: N=4M people. COVID ⬆️ risk of new autoimmune Dz & vaccine was protective https://t.co/LhLQMRP3HK

On #LongCovid A new Ground Truths on mitochondria as a potential root cause, the Big Miss, and where to go from here. Link not provided due to algorithmic X-suppression, but it's shown in my profile

New study finds that beta-blockers increase cardiovascular risk for sleep apnoea patients | UCL School of Pharmacy - UCL – University College London

Our paper on the ACSBT-D programme is out now - developed by applying the MRC framework for developing complex interventions to treat psychological distress among people with type 2 diabetes. https://t.co/73FxYUtJBz